FDA Drugs (New Approvals & NDA)Original article
Spa De Soleil, Inc. - 728508 - 07/08/2026
RegulatoryNegative
AI Analysis
Summary
Spa De Soleil, Inc. received an FDA regulatory notice regarding CGMP violations and adulterated finished pharmaceuticals (FDA ID 728508). This represents a compliance issue with pharmaceutical manufacturing standards.
Outcome Details
CGMP/Finished Pharmaceuticals/Adulterated
Importance:6/10
Sentiment:
-0.80
FDARegulatoryCGMPAdulterationCompliance
Read the original article
Published by FDA Drugs (New Approvals & NDA) on July 14, 2026 1:20 PM